v3.22.4
Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2019   114,959,000        
Beginning balance at Dec. 31, 2019   $ 564,697        
Ending balance (in shares) at Dec. 31, 2020   112,878,000        
Ending balance at Dec. 31, 2020   $ 562,467        
Beginning balance (in shares) at Dec. 31, 2019     66,994,000      
Beginning balance at Dec. 31, 2019 $ 497,086   $ 0 $ 93,820 $ (721) $ 403,987
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     2,038,000      
Issuance of common stock upon exercise of stock options, net of repurchases 16,707     16,707    
Repurchase of equity awards (1,930)     (1,930)    
Stock-based compensation expense 72,643     72,643    
Issuance of equity instruments as consideration for business combination (in shares)     1,304,000      
Issuance of equity instruments as consideration in business combination 31,349     31,349    
Issuance of common stock to settle contingent consideration (in shares)     691,000      
Issuance of common stock to settle contingent consideration 16,205     16,205    
Conversion of preferred stock (in shares)   (2,081,000) (2,081,000)      
Conversion of preferred stock 2,230 $ (2,230) $ 0 2,230    
Comprehensive loss 6,977       6,977  
Net income 322,317         322,317
Ending balance (in shares) at Dec. 31, 2020     73,108,000      
Ending balance at Dec. 31, 2020 $ 963,584   $ 0 231,024 6,256 726,304
Ending balance (in shares) at Dec. 31, 2021 0 0        
Ending balance at Dec. 31, 2021   $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     24,909,000      
Issuance of common stock upon exercise of stock options, net of repurchases $ 212,476     212,476    
Stock-based compensation expense 824,153     824,153    
Issuance of equity instruments as consideration for business combination (in shares)     3,985,000      
Issuance of equity instruments as consideration in business combination 544,588     544,588    
Conversion of preferred stock (in shares)   (112,878,000) (112,878,000)      
Conversion of preferred stock 562,467 $ (562,467) $ 2 562,465    
Issuance of common stock from exercise of warrants (in shares)     412,000      
Issuance of common stock from exercise of warrants 433     433    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)     1,775,000      
Issuance of common stock upon settlement of Restricted Stock Units ("RSUs") and restricted common stock, net of shares withheld (262,794)     (262,794)    
Purchase of capped calls (90,131)     (90,131)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)     50,000      
Issuance of common stock under the 2021 Employee Stock Purchase Plan (the "ESPP") 12,444     12,444    
Comprehensive loss (9,651)       (9,651)  
Net income 3,624,120         3,624,120
Ending balance (in shares) at Dec. 31, 2021     217,117,000      
Ending balance at Dec. 31, 2021 $ 6,381,689   $ 2 2,034,658 (3,395) 4,350,424
Ending balance (in shares) at Dec. 31, 2022 0 0        
Ending balance at Dec. 31, 2022   $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares) 3,858,000   3,883,000      
Issuance of common stock upon exercise of stock options, net of repurchases $ 56,737     56,737    
Stock-based compensation expense 1,683,840     1,683,840    
Issuance of equity instruments as consideration for business combination (in shares)     1,663,000      
Issuance of equity instruments as consideration in business combination 314,356     314,356    
Issuance of common stock to settle contingent consideration (in shares)     58,000      
Issuance of common stock to settle contingent consideration 4,661     4,661    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)     7,870,000      
Issuance of common stock upon settlement of Restricted Stock Units ("RSUs") and restricted common stock, net of shares withheld (351,867)     (351,867)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)     275,000      
Issuance of common stock under the 2021 Employee Stock Purchase Plan (the "ESPP") 21,622     21,622    
Other 3,679     3,679    
Comprehensive loss (35,211)       (35,211)  
Net income (2,624,949)         (2,624,949)
Ending balance (in shares) at Dec. 31, 2022     230,866,000      
Ending balance at Dec. 31, 2022 $ 5,454,557   $ 2 $ 3,767,686 $ (38,606) $ 1,725,475